You are here

  • Home
  • Archive
  • Volume 105, Issue 20
  • Do beta-blockers and inhibitors of the renin–angiotensin aldosterone system improve outcomes in patients with heart failure and left ventricular ejection fraction >40%?

Article info

Article menu
Download PDFPDF
Editorial
Do beta-blockers and inhibitors of the renin–angiotensin aldosterone system improve outcomes in patients with heart failure and left ventricular ejection fraction >40%?

Authors

  1. Correspondence to Dr R Thomas Lumbers, Institute of Health Informatics, University College London, London WC1E 6BT, UK; t.lumbers{at}ucl.ac.uk
View Full Text

Citation

Lumbers RT, Martin N, Manoharan K, et al
Do beta-blockers and inhibitors of the renin–angiotensin aldosterone system improve outcomes in patients with heart failure and left ventricular ejection fraction >40%?
Heart 2019;105:1533-1535.

Publication history

  • First published July 25, 2019.
Online issue publication 
September 26, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.